Mode Sensors launches new clinical trial for Re:Balans® hydration monitoring wearable

Mode Sensors (MODE) is pleased to announce the initiation of a new clinical trial at Solfjellhøgda Rehabilitation Centre, focusing on the evaluation of its Re:Balans wearable for hydration monitoring .

The trial aims to assess the technology's effectiveness in improving hydration management for patients in rehabilitation care.​ "This trial marks an exciting step forward in our mission to establish a new global standard for hydration monitoring," says Gøran van den Burgt, CEO of Mode Sensors.​

Solfjellshøgda Helsehus is one of four healthcare centers in Oslo Municipality, offering 142 patient rooms dedicated to assessment and rehabilitation services. The rehabiliation centre has long experience with sensor technology and other welfare technology.